Controlled-release transdermal drug delivery
- PMID: 3920010
Item in Clipboard
Controlled-release transdermal drug delivery
Cutis.
1985 Mar.
No abstract available
Similar articles
-
Transdermal delivery of drugs.Annu Rev Med. 1988;39:221-9. doi: 10.1146/annurev.me.39.020188.001253. Annu Rev Med. 1988. PMID: 3130771 Review.
-
[Transdermal therapeutic systems].Srp Arh Celok Lek. 1985 Oct;113(10):893-900. Srp Arh Celok Lek. 1985. PMID: 3938572 Serbian. No abstract available.
-
Prevention of experimental motion sickness by scopolamine absorbed through the skin.Aviat Space Environ Med. 1976 Oct;47(10):1096-100. Aviat Space Environ Med. 1976. PMID: 791234 Clinical Trial.
-
Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.Drugs. 1985 Mar;29(3):189-207. doi: 10.2165/00003495-198529030-00001. Drugs. 1985. PMID: 3886352 Review.
-
Dermatitis due to transdermal therapeutic systems.Cutis. 1984 Dec;34(6):526-7, 530-1. Cutis. 1984. PMID: 6240373 No abstract available.
Cited by
-
Factors affecting electrode-gel-skin interface impedance in electrical impedance tomography.Med Biol Eng Comput. 1996 Nov;34(6):397-408. doi: 10.1007/BF02523842. Med Biol Eng Comput. 1996. PMID: 9039740 Review.
-
Skin sensitivity and transdermal drug delivery. A review of the problem.Drug Saf. 1994 Feb;10(2):151-9. doi: 10.2165/00002018-199410020-00004. Drug Saf. 1994. PMID: 8011180 Review.